Please provide your email address to receive an email when new articles are posted on . Patients with high myopia can be at risk for ocular pathology, so managing, slowing and treating myopia in ...
Please provide your email address to receive an email when new articles are posted on . As the myopia epidemic continues to expand and affect children, management of the condition remains a source of ...
An overview of the top 10 stories from Optometry Times in 2025.
Ophthalmologists are raising alarms about an epidemic of childhood myopia. Nearsightedness typically develops between ages 3 ...
Boy searching the internet at home Researchers identify a substantial shift in myopia progression since the pandemic forced many indoors and on screens. Stay-at-home orders instituted during the ...
Credit: Getty Images. A PDUFA target date of January 31, 2024 has been set for the application. The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for NVK002 ...
Myopia, or nearsightedness, is an increasingly common eye condition that causes distant objects to appear blurry, often requiring corrective lenses. As the medical director of ophthalmology at ...
Childhood myopia progression could be treated with low-dose atropine due to the safety and efficacy displayed in this study. The global prevalence of myopia was estimated to be 30% to 34% in 2020 and ...
BENGALURU: Childhood myopia is emerging as a major public health concern, with doctors warning that post-COVID lifestyle ...
iVeena Awarded $2 Million National Eye Institute Grant to Advance Novel Therapy for Pediatric Myopia
Funding will support development of a first-in-class topical eye drop designed to slow the progression of myopia in children iVeena Delivery Systems, Inc. (“iVeena”), a clinical-stage ophthalmology ...
Discover how Remidio's PRISTINE OBM 12 enhances pediatric myopia care through automated biometry, increasing accuracy and ...
iVeena Awarded $2 Million National Eye Institute Grant to Advance Novel Therapy for Pediatric Myopia
Funding will support development of a first-in-class topical eye drop designed to slow the progression of myopia in children iVeena’s research is led by Sarah Molokhia, PhD, Vice President of Research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback